In August 2020, Arcapita, and Mumtalakat, the sovereign wealth fund of the Kingdom of Bahrain, announced the sale of their stake in NAS Neuron, a leading provider of outsourced medical claims processing services in the GCC, to a leading US based Fortune 500 company. The successful investment has exceeded target returns over a three-year holding period.

Investment Type

Private Equity


Middle East

Exit Date